IgG / Elsevier Inc. / Thermo Fisher Scientific Inc. / Dionex Corp / Molecular Biosciences / /
Country
United Kingdom / / /
Facility
Stable Isotope-Labeled Nucleolar Proteins Cells / C terminus / University of Dundee / Newcastle University / College of Life Sciences / Cancer Research UK London Research Institute / N terminus / N terminus of FMN2 / /
IndustryTerm
model human cell systems / microscope-based live-cell imaging / cell systems / search engine / /
MarketIndex
International Protein / /
MedicalCondition
human cancers / 2Institute SUMMARY The ARF tumor / human tumors / certain renal cancers / melanoma / ARF tumor / INTRODUCTION The ARF tumor / important tumor / FMN2 ORF / MS / leukemia / tumor / cancer / human leukemia / HPV / melanomas / certain breast cancers / cancer cells / ARF-mediated tumor / p14ARF tumor / human disease / certain cancer / osteosarcoma cell line U2OS / /
Organization
Newcastle University / Medical School / College of Life Sciences / Cancer Research UK London Research Institute / University of Dundee / /
Person
Gordon Peters / /
Product
NARF2E6 / RelA / etoposide / performed using anti-RelA and anti-AcH3 antibodies / /
ProvinceOrState
Mississippi / /
Technology
antibodies / siRNA / ATM / apoptosis / DNA Chip / analyzed using the indicated antibodies / /
Molecular Cell Article Identification and Functional Characterization of FMN2, a Regulator of the Cyclin-Dependent Kinase Inhibitor p21